Parkinson's & Movement disorders

Scientists uncover new targets for treating Parkinson's disease

Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells. The scientists hope that targeting these genes ...

Neuroscience

Dementia protein changes discovered in terminal childhood disease

In a world-first, researchers at Newcastle University have found that the brains of infants who sadly passed away with an extremely rare genetic condition, Krabbe disease, have similar changes to those seen in two age-related ...

Psychology & Psychiatry

How the brain helps us focus our attention

How can we shift from a state of inattentiveness to one of highest attention? The locus coeruleus, literally the "blue spot," is a tiny cluster of cells at the base of the brain. As the main source of the neurotransmitter ...

Diseases, Conditions, Syndromes

Dominant Alpha variant evolved to evade our innate immune system

The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...

Parkinson's & Movement disorders

Are scientists homing in on a cure for Parkinson's disease?

A molecule that shows promise in preventing Parkinson's disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.

Diseases, Conditions, Syndromes

UK study suggests COVID-19 became much more lethal in late 2020

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors—not just the alpha variant of the virus that causes COVID-19—were to blame. ...

page 5 from 33